Literature DB >> 8263500

Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology.

H I Thomas1, P Morgan-Capner, J E Cradock-Watson, G Enders, J M Best, S O'Shea.   

Abstract

Without appropriately timed specimens, serological confirmation of congenital rubella infection may be a problem. We have compared the persistence of specific IgM and low avidity specific IgG1 in 141 sera from 120 cases of serologically confirmed congenital rubella infection with the known time scales for postnatal primary rubella. The results demonstrate that the maturation of the immune response to the rubella virus is abnormally slow in congenital rubella cases both in terms of the isotype switch and especially the development of high avidity specific IgG1. Thus avidity studies may permit serological confirmation of congenital rubella for longer than is possible with tests currently in use. The pathological implications of prolonged low avidity antibody production are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263500     DOI: 10.1002/jmv.1890410305

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test.

Authors:  J Gutiérrez; M J Rodríguez; F De Ory; G Piédrola; M C Maroto
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome.

Authors:  Terri B Hyde; Helena Keico Sato; LiJuan Hao; Brendan Flannery; Qi Zheng; Kathleen Wannemuehler; Flávia Helena Ciccone; Heloisa de Sousa Marques; Lily Yin Weckx; Marco Aurélio Sáfadi; Eliane de Oliveira Moraes; Marisa Mussi Pinhata; Jaime Olbrich Neto; Maria Cecilia Bevilacqua; Alfredo Tabith Junior; Tatiana Alves Monteiro; Cristina Adelaide Figueiredo; Jon K Andrus; Susan E Reef; Cristiana M Toscano; Carlos Castillo-Solorzano; Joseph P Icenogle
Journal:  J Infect Dis       Date:  2014-10-31       Impact factor: 5.226

3.  Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Joan Marler; Nicolas Laven; Susan Leeson; Elizabeth M Dax
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

4.  Evaluation of commercial rubella immunoglobulin G avidity assays.

Authors:  Samira Mubareka; Hannah Richards; Michael Gray; Graham A Tipples
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

5.  Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument.

Authors:  Maria Cristina Medici; Monica Martinelli; Valeria Albonetti; Carlo Chezzi; Giuseppe Dettori
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

6.  Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

Authors:  J Gutiérrez; M Rodríguez; C Maroto; G Piédrola
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

7.  Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier' and "non-carrier' cattle.

Authors:  J S Salt; G Mulcahy; R P Kitching
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

Review 8.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS.

Authors:  F T Cutts; S E Robertson; J L Diaz-Ortega; R Samuel
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 9.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

10.  Immunoglobulin G avidity in the serodiagnosis of congenital rubella syndrome.

Authors:  V Herne; K Hedman; P Reedik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.